PROMIS and Mobility Evaluation in Sarcoma Patients

Abroad (travel likely)Recruiting

Conditions

Sarcoma · Giant Cell Tumor of Bone

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mayo Clinic, Phoenix, Arizona, United States

    Contact: Study coordinator (Krista A Goulding, MD MPH) · goulding.krista@mayo.edu · 480-342-2407
    Contact: Study coordinator (Ray Canez, BS) · Canez.Lupe@mayo.edu · 480-574-2753
    Contact: Principal Investigator (Krista A Goulding, MD MPH)
  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Matthew T Houdek, MD) · houdek.matthew@mayo.edu · 507-284-2995
    Contact: Principal Investigator (Matthew T Houdek, MD)
  • Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of Calgary, Calgary, Alberta, Canada

    Contact: Study coordinator (Joseph K Kendal, MD MSc FRCSC) · jkkendal@ucalgary.ca · 403-944-4793
    Contact: Study coordinator (Alyssa A Federico, MD) · alyssa.federico@ucalgary.ca · 403-650-5071
    Contact: Principal Investigator (Joseph K Kendal, MD MSc FRCSC)
    Michael J Monument, MD MSc FRCSC (Sub-investigator)
    Shannon Puloski, MD FRCSC (Sub-investigator)
  • Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

    Contact: Study coordinator (Jay S Wunder, MD MSc FRCSC) · jay.wunder@sinaihealth.ca · 416-586-4800
    Contact: Study coordinator (Anthony Griffin, MSc) · anthony.griffin@sinaihealth.ca · 416-586-4800
    Contact: Principal Investigator (Jay S Wunder, MD MSc FRCSC)
    Peter C Ferguson, MD MSc FRCSC FAOA (Sub-investigator)
    Aaron M Gazendam, MD MSc FRCSC (Sub-investigator)
    Kim Tsoi, MD PhD FRCSC (Sub-investigator)